Peking University People's Hospital is the world's largest haploidentical stem cell transplant centre and the home of the Beijing Protocol that lets almost any patient find a donor.
Its Institute of Hematology, led by Huang Xiaojun, developed the Beijing Protocol for haploidentical transplantation without in vitro T-cell depletion (Bone Marrow Transplantation 2006), now the dominant transplant approach in China and adopted by centres elsewhere; it performs more than a thousand transplants a year. Also a major site for CAR-T, leukaemia and lymphoma trials and the hospital's Breast Center and hepatobiliary units.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-15.
Matched to Peking University People's Hospital, including child institutions. 446 works · 3,208 citations · 76% open access · 9% clinical trials · 3% reviews.
Shares CAR-T cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia and the tag china.
Shares CAR-T cell therapy, Acute lymphoblastic leukaemia and the tag china.
Shares CAR-T cell therapy, Acute lymphoblastic leukaemia and the tag china.
Shares CAR-T cell therapy and the tag china.
Shares Acute myeloid leukaemia and the tag china.
Shares CAR-T cell therapy and the tag china.
Shares CAR-T cell therapy and the tag china.
Shares Acute myeloid leukaemia and the tag china.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/